Clinical Trial Update: Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating adjuvant oral decitabine and tetrahydrouridine, with or without celecoxib, in patients undergoing pulmonary metastasectomy has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor
• Melanoma
• Sarcoma

Drugs mentioned

• Celecoxib (Celecoxib)
• Decitabine (Decitabine)
• Tetrahydrouridine (tetrahydrouridine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasm Metastasis, Sarcoma | Phase 1 | Status: WITHDRAWN